CUTISS
Agent23 out of 100, Bottom 25%. Agent Readiness. Open the scores section.Agent Readiness: 23/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust64 out of 100, Above median. Data Trust. Open the scores section.Data Trust: 64/100. Above median. Measured by StartupHub.ai. Median 61.Pioneering bio-engineered skin grafts for severe burns and chronic wounds.
About
CUTISS is a late-stage clinical TechBio company revolutionizing skin surgery with denovoSkin™, a first-in-class personalized tissue therapy for on-demand production of living human skin. This technology is designed for patients requiring skin surgery, from severe burns to reconstructive and aesthetic applications, offering a safe and effective alternative to the standard of care. CUTISS also leverages its scalable, automated production platform for advancements in regenerative medicine, space health research, and industrial bioengineered tissue applications.
Similar companies
Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.
Shares Biotech, MedTech
Develops a point-of-care diagnostic platform for rapid and accurate disease detection.
Shares MedTech, HealthTech
Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions.
Shares MedTech, Biotech
Bioplasmar is developing a novel plasma-based technology for advanced wound care and tissue regeneration.
Shares MedTech, HealthTech
Organox develops and commercializes medical devices for organ preservation and assessment, aiming to improve outcomes for transplant patients.
Shares MedTech, Biotech
Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.
Shares Regenerative Medicine, Tissue Engineering
Key facts
- Website
- cutiss.swiss
- Headquarters
- Zurich, Switzerland
- Founded
- 2014
- Total funding
- $135M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Sept 2025 | Series C | $63M | Swiss Entrepreneurs Fund, Giammaria Giuliani |
| 29 Mar 2022 | Undisclosed round | $50M | |
| 1 Mar 2021 | Undisclosed round | $10M | Giammaria Giuliani Foundation |
| 1 Jan 2019 | Undisclosed round | $3M | |
| 1 Sept 2017 | Undisclosed round | $8M | Giammaria Giuliani Foundation |
| 1 Jan 2016 | Undisclosed round | $2M |
Tech stack
Detected on cutiss.swiss, last scanned 30 Oct 2026. Run your own scan
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is CUTISS trustworthy and reputable?
StartupHub's Data Trust & Reputation score for CUTISS is 64 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has CUTISS raised?
CUTISS has raised a total of $135M in funding. The most recent round on record is Series C.
SEC filings, insider activity, nonprofit links and pay benchmarks for CUTISS:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
